-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 RKV8aR0s/SKmCtiazq4IHarnFVt/NNV2dr/rpqx0KlxQmeHVLCgs44nzJTGxFQFA
 xcT6nORRN+A3MNznSU7DCQ==

<SEC-DOCUMENT>0001022079-08-000024.txt : 20080327
<SEC-HEADER>0001022079-08-000024.hdr.sgml : 20080327
<ACCEPTANCE-DATETIME>20080327164239
ACCESSION NUMBER:		0001022079-08-000024
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20080325
FILED AS OF DATE:		20080327
DATE AS OF CHANGE:		20080327

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			QUEST DIAGNOSTICS INC
		CENTRAL INDEX KEY:			0001022079
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		IRS NUMBER:				161387862
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		THREE GIRALDA FARMS
		CITY:			MADISON
		STATE:			NJ
		ZIP:			07940
		BUSINESS PHONE:		9735202700

	MAIL ADDRESS:	
		STREET 1:		THREE GIRALDA FARMS
		CITY:			MADISON
		STATE:			NJ
		ZIP:			07940

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CORNING CLINICAL LABORATORIES INC
		DATE OF NAME CHANGE:	19960903

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			PREVOZNIK MICHAEL E
		CENTRAL INDEX KEY:			0001222679

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-12215
		FILM NUMBER:		08715523

	BUSINESS ADDRESS:	
		STREET 1:		QUEST DIAGNOSTICS INC
		STREET 2:		ONE MALCOLM AVE
		CITY:			TETERBORO
		STATE:			NJ
		ZIP:			07608
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>doc.xml
<DESCRIPTION>PRIMARY DOCUMENT
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0202</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2008-03-25</periodOfReport>

    <issuer>
        <issuerCik>0001022079</issuerCik>
        <issuerName>QUEST DIAGNOSTICS INC</issuerName>
        <issuerTradingSymbol>DGX</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001222679</rptOwnerCik>
            <rptOwnerName>PREVOZNIK MICHAEL E</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O QUEST DIAGNOSTICS INCORPORATED</rptOwnerStreet1>
            <rptOwnerStreet2>3 GIRALDA FARMS</rptOwnerStreet2>
            <rptOwnerCity>MADISON</rptOwnerCity>
            <rptOwnerState>NJ</rptOwnerState>
            <rptOwnerZipCode>07940</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>1</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle>SVP &amp; General Counsel</officerTitle>
            <otherText></otherText>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <transactionDate>
                <value>2008-03-25</value>
            </transactionDate>
            <deemedExecutionDate></deemedExecutionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionTimeliness>
                <value></value>
            </transactionTimeliness>
            <transactionAmounts>
                <transactionShares>
                    <value>2208</value>
                    <footnoteId id="F1"/>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>32089</value>
                    <footnoteId id="F2"/>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
        <nonDerivativeHolding>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>4240</value>
                    <footnoteId id="F3"/>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>I</value>
                </directOrIndirectOwnership>
                <natureOfOwnership>
                    <value>401K/SDCP</value>
                </natureOfOwnership>
            </ownershipNature>
        </nonDerivativeHolding>
    </nonDerivativeTable>

    <derivativeTable></derivativeTable>

    <footnotes>
        <footnote id="F1">Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated January 1, 2006, approved in accordance with the requirements of Rule 16b-3(d).</footnote>
        <footnote id="F3">These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k) and/or Supplemental Deferred Compensation Plan.  The information was obtained from the plan administrator as of a recent date.  The number of shares is based on the account balance of the Company stock fund under the plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.</footnote>
        <footnote id="F2">The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>William J. O'Shaughnessy, Jr., atty-in-fact for Michael E. Prevoznik</signatureName>
        <signatureDate>2008-03-27</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----